- Home
- MPB vs SGMO Comparison
MPB vs SGMO Comparison
Compare MPB & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPB
- SGMO
- Stock Information
- Founded
- MPB 1868
- SGMO 1995
- Country
- MPB United States
- SGMO United States
- Employees
- MPB N/A
- SGMO N/A
- Industry
- MPB Major Banks
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MPB Finance
- SGMO Health Care
- Exchange
- MPB Nasdaq
- SGMO Nasdaq
- Market Cap
- MPB 525.0M
- SGMO 488.2M
- IPO Year
- MPB N/A
- SGMO 2000
- Fundamental
- Price
- MPB $29.78
- SGMO $1.13
- Analyst Decision
- MPB Buy
- SGMO Buy
- Analyst Count
- MPB 2
- SGMO 5
- Target Price
- MPB $36.00
- SGMO $5.20
- AVG Volume (30 Days)
- MPB 67.9K
- SGMO 10.5M
- Earning Date
- MPB 01-28-2025
- SGMO 03-12-2025
- Dividend Yield
- MPB 2.68%
- SGMO N/A
- EPS Growth
- MPB 14.41
- SGMO N/A
- EPS
- MPB 2.91
- SGMO N/A
- Revenue
- MPB $173,416,000.00
- SGMO $52,291,000.00
- Revenue This Year
- MPB N/A
- SGMO N/A
- Revenue Next Year
- MPB $19.26
- SGMO $5.97
- P/E Ratio
- MPB $10.26
- SGMO N/A
- Revenue Growth
- MPB 4.93
- SGMO N/A
- 52 Week Low
- MPB $19.20
- SGMO $0.30
- 52 Week High
- MPB $33.87
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- MPB 55.01
- SGMO 37.01
- Support Level
- MPB $28.48
- SGMO $1.00
- Resistance Level
- MPB $29.25
- SGMO $1.18
- Average True Range (ATR)
- MPB 0.70
- SGMO 0.15
- MACD
- MPB 0.23
- SGMO -0.04
- Stochastic Oscillator
- MPB 93.36
- SGMO 13.84
About MPB Mid Penn Bancorp
Mid Penn Bancorp Inc operates in the financial services domain. It conducts commercial banking and trust business in the United States. Its range of services comprises mortgage and home equity loans, secured and unsecured consists and consumer loans, lines of credit, construction financing, farm loans, community development, local government loans, and various types of time and demand deposits.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.